VV913 15mg group

DRUG2 trials

Sponsors

Vigonvita Life Sciences

Conditions

Healthy Volunteers

Early Phase 1

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules

RecruitingNCT07507838

Vigonvita Life SciencesHealthy Volunteers

Start: 2026-04-13End: 2026-12-31Target: 24Updated: 2026-07-14

Phase 1

Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants

RecruitingNCT07372703

Vigonvita Life SciencesHealthy Volunteers

Start: 2026-01-29End: 2026-10-01Target: 56Updated: 2026-05-04